PET‐CT confirmed complete remission and MRD negativity in mantle cell lymphoma patients treated with R‐hyper‐CVAD results in excellent outcome in the absence of autologous stem cell transplantation: a single‐centre case for a transplant‐free approach

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|46|9|1113-1114

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.46, Iss.9, 2016-09, pp. : 1113-1114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3318-3325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Equivalence of Pegfilgrastim and Filgrastim in Lymphoma Patients Treated with BEAM Followed by Autologous Stem Cell Transplantation

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 93-97

Karger

Access to resources Recommend Favorite

Outcome prediction by extranodal involvement, IPI, R‐IPI, and NCCN‐IPI in the PET/CT and rituximab era: A Danish–Canadian study of 443 patients with diffuse‐large B‐cell lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1041-1046

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Meta-Analysis of Randomized Trials

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-07 ,pp. : 61-71

Karger

Access to resources Recommend Favorite

Autologous Stem Cell Transplantation as the First-Line Treatment for Peripheral T Cell Lymphoma: Results of a Comprehensive Meta-Analysis

By  

Acta Haematologica, Vol. 131, Iss. 2, 2013-10 ,pp. : 114-125

Karger

Access to resources Recommend Favorite